55 KiB
title, docid, authors, breadcrumbs, category, cmeTopicId, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, tables, breadcrumbs
| title | docid | authors | breadcrumbs | category | cmeTopicId | documentVersionId | imageCount | lastUpdated | pageDescription | pageKeywords | pageTitle | enhancedTitle | type | references | tables | breadcrumbs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frontotemporal Lobar Degeneration | 49510d0e-acf7-45cb-9eb1-53f8193b0b6d |
|
|
Brain | 144a695e-95a4-4ec7-8df6-1c4db98375f6 | 857bab94-d633-4e44-a081-50f182d9ed83 | 30 | 09/30/20 | Frontotemporal Lobar Degeneration | Brain, Diagnosis, Pathology-Based Diagnoses, Acquired Toxic/Metabolic/Degenerative Disorders, Dementias and Degenerative Disorders, Frontotemporal Lobar Degeneration | Frontotemporal Lobar Degeneration | STATdx | Frontotemporal Lobar Degeneration | DX | true | 1 |
|
title: "Frontotemporal Lobar Degeneration" docid: "49510d0e-acf7-45cb-9eb1-53f8193b0b6d" authors:
- key: "1fa14dfd-71ea-4960-908e-e720313bc63a" value: "Santhosh Gaddikeri, MD"
- key: "a25c450b-3d34-4f64-bba3-cc0834813df6" value: "Miral D. Jhaveri, MD, MBA" breadcrumbs:
- name: "Brain" slug: "brain" treeNodeId: "6d8829f1-14d7-45af-8675-255189aa526a"
- name: "Diagnosis" slug: "diagnosis" treeNodeId: "51c00394-446e-4a38-94af-d3b1d14d34e8"
- name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "d9d3a8ed-f21b-4831-8c77-591a3500ef77"
- name: "Acquired Toxic/Metabolic/Degenerative Disorders" slug: "acquired-toxicmetabolicdegenerativ-" treeNodeId: "ba3cfeaf-64d9-4117-91e8-d2ce58783fc5"
- name: "Dementias and Degenerative Disorders" slug: "dementias-and-degenerative-disorde-" treeNodeId: "6381104d-7a4c-4be5-bb19-3cd90837d547"
- name: "Frontotemporal Lobar Degeneration" slug: "frontotemporal-lobar-degeneration" treeNodeId: null category: "Brain" cmeTopicId: "144a695e-95a4-4ec7-8df6-1c4db98375f6" documentVersionId: "857bab94-d633-4e44-a081-50f182d9ed83" imageCount: 30 lastUpdated: "09/30/20" pageDescription: "Frontotemporal Lobar Degeneration" pageKeywords: "Brain, Diagnosis, Pathology-Based Diagnoses, Acquired Toxic/Metabolic/Degenerative Disorders, Dementias and Degenerative Disorders, Frontotemporal Lobar Degeneration" pageTitle: "Frontotemporal Lobar Degeneration | STATdx" enhancedTitle: "Frontotemporal Lobar Degeneration" type: "DX" references: true tables: 1 breadcrumbs:
- "Brain"
- "Diagnosis"
- "Pathology-Based Diagnoses"
- "Acquired Toxic/Metabolic/Degenerative Disorders"
- "Dementias and Degenerative Disorders"
- "Frontotemporal Lobar Degeneration"
KEY FACTS
-
Terminology
- Clinical subtypes - Behavioral variant frontotemporal dementia (bvFTD) - Primary progressive aphasia syndromes (PPA) - Semantic variant (sv-PPA): Previously known as semantic dementia - Nonfluent/agrammatic variant (nfv-PPA): Previously known as progressive nonfluent aphasia - Logopenic variant (lv-PPA) - Frontotemporal dementia with motor symptoms
-
Imaging
- Early - PET shows frontotemporal ↓ glucose metabolism
- Late: Frontotemporal atrophy with knife-like gyri on MR
- Subtypes have characteristic cortical atrophy patterns
-
Top Differential Diagnoses
- Alzheimer dementia (AD)
- Vascular dementia
- Corticobasal ganglionic degeneration (CBD)
- Dementia with Lewy bodies (DLB)
-
Clinical Issues
- Clinical syndromes (some overlap) - bvFTD: Disinhibition, apathy & loss of empathy, hyperorality, & compulsive behavior - sv-PPA: Impaired single-word comprehension & object naming with preserved fluency, repetition, & grammar - nfv-PPA: Effortful speech production of phonemes (linguistic units of sound) & orofacial apraxia - lv-PPA: Impaired word finding & repetition with errors in speech & naming
- Younger age group than AD
- FTLD most common cause of early-onset (< 65 years) dementia
- Median survival: 6-11 years from symptom onset & 3-4 years from diagnosis
TERMINOLOGY
-
Abbreviations
- Frontotemporal lobar degeneration (FTLD)
- Clinical subtypes - Behavioral variant frontotemporal dementia (bvFTD) - Primary progressive aphasia syndromes (PPA) - Semantic variant (sv-PPA): Previously known as semantic dementia - Nonfluent/agrammatic variant (nfv-PPA): Previously known as progressive nonfluent aphasia - Logopenic variant**(lv-PPA)**: Has Alzheimer pathology & is not included as 1 of 3 clinical FTD syndromes
- Frontotemporal dementia (FTD) with motor symptoms - Corticobasal degeneration (CBD) - Progressive supranuclear palsy (PSP) - FTD with motor neuron disease - FTD with amyotrophic lateral sclerosis (ALS)
-
Synonyms
- Pick disease no longer used - Referred to pathologic variant with Pick bodies
-
Definitions
- Heterogeneous family of neurodegenerative disorders characterized by focal lobar degeneration of frontal &/or temporal lobes
IMAGING
-
General Features
-
Best diagnostic clue
- Structural & functional imaging are supportive but not diagnostic of FTD - PET showing frontotemporal ↓ glucose metabolism - Anterior frontotemporal atrophy with knife-like gyri -
Location
- Anterior temporal/frontal lobes, orbitofrontal cortex, medial temporal region - Relative sparing of parietooccipital lobes -
Morphology
- Knife blade appearance of atrophic gyri - ± marked asymmetry - May have worst atrophy in dominant hemisphere
-
-
CT Findings
-
NECT
- Frontal lobe atrophy often most prominent feature - ↑ size of frontal horns (larger than rest of lateral ventricles)
-
-
MR Findings
-
T1WI
- Atrophy of frontal & temporal lobes, often asymmetric - Knife-like gyri with normal signal - Dilated frontal sulci reflecting atrophy - Relative sparing of parietooccipital lobes -
T2WI
- ± hyperintensity in frontotemporal white matter (WM) -
FLAIR
- ± hyperintensity in frontotemporal WM -
MRS
- ↓ NAA glutamate + glutamine (neuronal loss), ↑ myoinositol (↑ glial content) in frontal lobes - ↓ NAA in posterior cingulate gyri - Reflects ↓ neuronal population, viability - ± lactate peak in frontal lobes -
MR voxel-based morphometry - Subtypes have characteristic cortical atrophy patterns - Frontal vs. temporal, left vs. right help discriminate - bvFTD: Atrophy of frontal & temporal lobes - Anterior insula, anterior cingulate, orbitofrontal cortex, & amygdala (early changes occur in right hemisphere) - sv-PPA: Typically anterior temporal lobe atrophy (asymmetric to left) - Entire temporal lobe can be involved - Ventromedial & superior frontal lobes - Right temporal atrophy as disease progresses - nfv-PPA: Selective left posterior frontoinsular region - lv-PPA: Predominant atrophy of left posterior temporal cortex & parietal lobe
-
DTI - Widespread damage to WM tracts reported - bvFTD: Uncinate fasciculus, inferior longitudinal fasciculus, & anterior commissural fibers - sv-PPA: Inferior longitudinal & uncinate fasciculi - nfv-FTD: Left superior longitudinal fasciculus - lv-PPA: Widespread dorsal & ventral WM tracts
-
-
Nuclear Medicine Findings
-
PET
- Functional imaging more sensitive than MR in early-stage disease - FDG PET: ↓ metabolic activity in frontotemporal cortex - Amyloid PET helps differentiate FTLD from Alzheimer disease (AD) -
HMPAO-SPECT - Sensitive technique for early detection of FTD - Occurs before atrophy is evident - bvFTD: ↓ perfusion frontal & anterior temporal lobes - Asymmetric, left or right dominant - sv-PPA: Prominent anterior temporal hypoperfusion, left > right - nfv-PPA: Asymmetric frontal hypoperfusion often involving insular cortex - lv-PPA: ↓ perfusion in left parietal inferior lobule & posterolateral temporal lobe
-
SPECT perfusion deficits predominantly in frontal & anterior temporal lobes with preserved perfusion posteriorly - Helps distinguish FTD from AD
-
Reduced frontal perfusion is not specific to FTD but also occurs in some cases of schizophrenia, depression, HIV encephalopathy, Creutzfeldt-Jakob disease, AD
-
-
Imaging Recommendations
-
Best imaging tool
- PET/SPECT; MR voxel-based morphometry -
Protocol advice
- Routine T1WI, T2WI, coronal T2WI MR
-
DIFFERENTIAL DIAGNOSIS
- Alzheimer Disease
- Parietal & temporal cortical atrophy with disproportionate hippocampal volume loss
- Increased rate of atrophy in FTD compared to AD
- Often coexisting microvascular disease, WM hyperintensities, microhemorrhages
- Amyloid imaging (11C-labeled Pittsburgh Compound-B) helps to differentiate AD from other dementias
- Vascular Dementia
- 2nd most common dementia (15-30%)
- WM & deep gray lacunae
- Hyperintense lesions on T2WI & focal atrophy is suggestive of chronic infarcts
- Corticobasal Degeneration
- Prominent extrapyramidal, cortical symptoms
- Severe frontoparietal atrophy contralateral to more severely affected clinically
- Atrophy of paracentral structures
- Dementia With Lewy Bodies
- Hypometabolism of entire brain, especially visual cortex
- Visual & auditory hallucinations, paranoid delusions
PATHOLOGY
-
General Features
-
Etiology
- Tau protein (hyperphosphorylated microtubular protein) or TDP-43 (TAR DNA-binding protein-43) - Rare cases change on fused-in-sarcoma (FUS) protein -
Genetics
- FTD is highly heritable without clear inheritance pattern - 25-40% of FTD is familial, > 50% of bvFTD is autosomal dominant - Mutations in following 3 genes together constitute 15% of FTD cases - Most common: Hexanucleotide expansion in chromosome 9 open reading frame 72 (*C9orf72*) gene - Microtubule-associated protein tau (*MAPT*) gene - Granulin precursor (*GRN*) gene
-
-
Staging, Grading, & Classification
- Histopathologic classification of FTLD based on abnormal inclusions - FTLD-tau: Tau inclusion (hyperphosphorylated tau protein)/Pick bodies - FTLD-TDP: Tau-negative & TDP-43-positive inclusions (subtypes: Type A, B, C, & D) - FTLD-FUS: Tau-/TDP-negative & FUS-positive inclusions - FTLD-ALS/dipeptide repeats (DPR): TDP-negative DPR protein aggregates - FTLD-ni: No inclusions
- FTD clinical syndromes correlate with brain atrophy patterns & not with pathologic subtypes
-
Gross Pathologic & Surgical Features
- Gross atrophy of frontal &/or anterior temporal lobes
- Firm cortical gray matter (gliosis) &/or basal ganglia atrophy
- Soft, retracted subcortical WM
-
Microscopic Features
- Loss of pyramidal neurons & microvacuolar degeneration in layer II & III of frontal & temporal cortex
- Subjacent WM shows axonal & myelin loss
- FTLD-related tauopathies - Pick disease: Prototypical tauopathy of FTLD - Characterized by Pick bodies: Solitary, round or oval, argyrophilic inclusions in cytoplasm of neurons - Commonly found in dentate gyrus of hippocampus, amygdala, frontal & temporal neocortex
CLINICAL ISSUES
-
Presentation
-
Most common signs/symptoms
- Personality, behavior, & language changes - Memory loss, confusion, cognitive & speech dysfunction, apathy, & abulia -
Clinical profile
- **bvFTD**: Disinhibition, apathy & loss of empathy, hyperorality, & compulsive behavior - 15-20% may develop concomitant motor neuron disease (MND) - **sv-PPA**: Impaired single-word comprehension & object naming with preserved fluency, repetition, & grammar - **nfv-PPA**: Effortful speech production of phonemes (linguistic units of sound) & orofacial apraxia - **lv-PPA**: Impaired word finding & repetition with errors in speech & naming
-
-
Demographics
-
Age
- More common cause of early-onset (midlife) dementia - Mean age of onset is 58 years; rare < 40 & > 75 years - Peak incidence 45-65 years -
Sex
- bvFTD & sv-FTD: Male preponderance - nfv-PPA: Female predominance -
Ethnicity
- Familial forms of Pick complex dementias particularly common in people of Scandinavian origin -
Epidemiology
- FTLD more common cause of early-onset (< 65 years) dementia - Age > 65 years account for 20-25% of cases of FTLD - Prevalence: 3.5-15/100,000 person-years - FTLD accounts for ~ 5% of all pathologic diagnoses in patients with dementia
-
-
Natural History & Prognosis
- Insidious onset of behavioral & cognitive dysfunction
- Speech & language disturbance are often more profound than memory disorder
- Median survival 6-11 years from symptom onset & 3-4 years from diagnosis
- Currently no FDA-approved disease-modifying drugs available for treatment of FTD
- Some patients develop artistic talents during course of dementia (disinhibition of "creative" brain areas)
DIAGNOSTIC CHECKLIST
-
Consider
- Other common forms of dementia (AD, dementia with Lewy bodies)
-
Image Interpretation Pearls
- Bilateral frontal lobe atrophy should make one consider diagnosis of FTD
- Bilateral asymmetric anterior temporal lobe atrophy: sv-PPA
-
Reporting Tips
- Report pattern of cortical volume loss
52f7139c-657b-4ff0-8be5-0f3d7523130e
References
Selected References
- Ishii K: Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Jpn J Radiol. 38(1):64-76, 2020
- Raji CA et al: Overview of MR imaging volumetric quantification in neurocognitive disorders. Top Magn Reson Imaging. 28(6):311-5, 2019
- Risacher SL et al: Neuroimaging in aging and neurologic diseases. Handb Clin Neurol. 167:191-227, 2019
- Shepherd TM et al: Clinical use of integrated positron emission tomography-magnetic resonance imaging for dementia patients. Top Magn Reson Imaging. 28(6):299-310, 2019
- Zukotynski K et al: PET/CT of dementia. AJR Am J Roentgenol. 211(2):246-59, 2018
- Mann DM et al: Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype. Brain Pathol. 27(6):723-36, 2017
- Bang J et al: Frontotemporal dementia. Lancet. 386(10004):1672-82, 2015
- Shivamurthy VK et al: Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol. 204(1):W76-85, 2015
- Bott NT et al: Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag. 4(6):439-54, 2014
- Chare L et al: New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry. 85(8):865-70, 2014
- Diehl-Schmid J et al: Imaging frontotemporal lobar degeneration. Curr Neurol Neurosci Rep. 14(10):489, 2014
- Bhogal P et al: The common dementias: a pictorial review. Eur Radiol. 23(12):3405-17, 2013
- Risacher SL et al: Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol. 33(4):386-416, 2013
- Gorno-Tempini ML et al: Classification of primary progressive aphasia and its variants. Neurology. 76(11):1006-14, 2011
- Rascovsky K et al: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 134(Pt 9):2456-77, 2011
- Krueger CE et al: Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease. Alzheimer Dis Assoc Disord. 24(1):43-8, 2010
- Mackenzie IR et al: Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119(1):1-4, 2010
- King RD et al: Characterization of atrophic changes in the cerebral cortex using fractal dimensional analysis. Brain Imaging Behav. 3(2):154-66, 2009
- Lindberg O et al: Cortical morphometric subclassification of frontotemporal lobar degeneration. AJNR Am J Neuroradiol. 30(6):1233-9, 2009
- Moon WJ et al: Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects? AJNR Am J Neuroradiol. 29(7):1308-13, 2008
- Mihara M et al: Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex. Neuroreport. 17(4):413-6, 2006
- Whitwell JL et al: Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol. 62(9):1402-8, 2005
Tables
Imaging Features for Various Clinical Subtypes of Frontotemporal Dementia
| Clinical Subtypes | Imaging Features |
|---|---|
| bvFTD | MR: Atrophy of frontal & temporal lobes; asymmetric right frontal &/or temporal lobe atrophy may occur NM: Decreased perfusion & metabolism in frontal &/or temporal lobes, usually asymmetric to right side |
| sv-PPA | MR: Typically atrophy of left anterior & inferior temporal lobe; right temporal lobe atrophies as disease progresses NM: Decreased perfusion & metabolism in anterior temporal lobes (L > > R) |
| nfv-PPA | MR: Selective left perisylvian & frontal atrophy NM: Asymmetric decreased perfusion & metabolism in frontal lobes (L > > R) often involving insular cortex |
| lv-PPA | MR: Prominent atrophy of left angular & middle temporal gyri NM: Decreased perfusion & metabolism in left parietal inferior lobule & posterolateral temporal lobe |
Images
Selected Images
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Graphic depicts the classic disproportionate frontal lobe atrophy of late-stage frontotemporal dementia (FTD). The sulci are widened & gyri are knife-like
. Parietooccipital lobes are spared. Gyri around the central sulcus are normal.
Coronal NECT MPR through the frontal lobes of a 62-year-old man with behavioral variant frontotemporal dementia (bvFTD) shows asymmetric atrophy of right frontal lobe
with relatively preserved left frontal lobe volume
.
Coronal NECT MPR through the frontal lobes of a 62-year-old man with behavioral variant frontotemporal dementia (bvFTD) shows asymmetric atrophy of right frontal lobe
with relatively preserved left frontal lobe volume
.
Coronal T2WI MR of a 55-year-old woman with nfv-PPA shows diffuse brain parenchymal atrophy, which is more pronounced in the left perisylvian region
due to atrophy of adjacent inferior & lateral temporal convexity
and frontal operculum
.
Coronal T2WI MR of a 55-year-old woman with nfv-PPA shows diffuse brain parenchymal atrophy, which is more pronounced in the left perisylvian region
due to atrophy of adjacent inferior & lateral temporal convexity
and frontal operculum
.
Parasagittal T1WI MR through left (top) & right (bottom) temporal lobes of a 55-year-old man with sv-PPA shows asymmetric temporal lobe atrophy on left
vs. right
. Also note relatively preserved frontal lobe
volume.
Parasagittal T1WI MR through left (top) & right (bottom) temporal lobes of a 55-year-old man with sv-PPA shows asymmetric temporal lobe atrophy on left
vs. right
. Also note relatively preserved frontal lobe
volume.
FDG PET raw data & 3D-SSP images of a 59-year-old man with sv-PPA demonstrate decreased metabolic activity in the anterior & medial left temporal lobe
& to a lesser degree in anterior & medial temporal lobe
. (Courtesy M. Matesan, MD.)
FDG PET raw data & 3D-SSP images of a 59-year-old man with sv-PPA demonstrate decreased metabolic activity in the anterior & medial left temporal lobe
& to a lesser degree in anterior & medial temporal lobe
. (Courtesy M. Matesan, MD.)
Axial T2WI MR in a patient with classic FTD shows predominantly frontal lobar atrophy with knife-like gyri
. In this case, an associated region of hyperintense white matter
is present.
Axial T2WI MR in a patient with classic FTD shows predominantly frontal lobar atrophy with knife-like gyri
. In this case, an associated region of hyperintense white matter
is present.
Axial FDG PET of a 55-year-old woman with sv-PPA (clinical subtype of FTD) shows decreased metabolic activity in the left temporal lobe
& to a lesser degree in the right temporal lobe
. Note relative sparing of parietal & occipital lobes
.
Axial FDG PET of a 55-year-old woman with sv-PPA (clinical subtype of FTD) shows decreased metabolic activity in the left temporal lobe
& to a lesser degree in the right temporal lobe
. Note relative sparing of parietal & occipital lobes
.
Axial FLAIR MR in the same patient shows asymmetric atrophy of bilateral temporal lobes (left > right) with knife-like gyri
. (Courtesy M. Matesan, MD.)
Axial FLAIR MR in the same patient shows asymmetric atrophy of bilateral temporal lobes (left > right) with knife-like gyri
. (Courtesy M. Matesan, MD.)
Axial color-coded FDG PET in a 65-year-old man with apathy & slowly progressive behavioral changes with clinical diagnosis of bvFTD shows decreased metabolic activity in bilateral anterior & medial temporal lobes
with relative sparing of bilateral parietooccipital lobes
.
Axial color-coded FDG PET in a 65-year-old man with apathy & slowly progressive behavioral changes with clinical diagnosis of bvFTD shows decreased metabolic activity in bilateral anterior & medial temporal lobes
with relative sparing of bilateral parietooccipital lobes
.
Sagittal reformat of color-coded FDG PET in the same patient shows decreased metabolic activity in the frontal lobe
. (Courtesy J. Singh, MD.)
Sagittal reformat of color-coded FDG PET in the same patient shows decreased metabolic activity in the frontal lobe
. (Courtesy J. Singh, MD.)
Additional Images
Sagittal T1WI MR demonstrates marked atrophy of the frontal lobe in a patient with FTD.
Sagittal T1WI MR demonstrates marked atrophy of the frontal lobe in a patient with FTD.
Coronal T1WI MR in a patient with FTD shows prominent atrophy of both frontal lobes, which appears more pronounced on the left side.
Coronal T1WI MR in a patient with FTD shows prominent atrophy of both frontal lobes, which appears more pronounced on the left side.
Axial NECT demonstrates predominantly frontal lobe volume loss from FTD.
Axial NECT demonstrates predominantly frontal lobe volume loss from FTD.
Axial T2WI MR in a patient with FTD shows marked frontal lobe atrophy.
Axial T2WI MR in a patient with FTD shows marked frontal lobe atrophy.
Axial FLAIR MR shows frontal lobe volume loss as well as associated hyperintense signal in white matter.
Axial FLAIR MR shows frontal lobe volume loss as well as associated hyperintense signal in white matter.
Axial T2WI MR in a patient with FTD demonstrates marked volume loss as well as associated hyperintense signal within bilateral temporal lobes.
Axial T2WI MR in a patient with FTD demonstrates marked volume loss as well as associated hyperintense signal within bilateral temporal lobes.
FDG PET in a patient with FTD & dementia depicts glucose hypometabolism (green regions in the cortex) in the frontal lobes. (Courtesy N. Foster, MD & the University of Michigan PET Center.)
FDG PET in a patient with FTD & dementia depicts glucose hypometabolism (green regions in the cortex) in the frontal lobes. (Courtesy N. Foster, MD & the University of Michigan PET Center.)
FDG PET in the same patient shows a decreased rate of glucose metabolism in the frontal & temporal lobes, consistent with FTD. (Courtesy N. Foster, MD & the University of Michigan PET Center.)
FDG PET in the same patient shows a decreased rate of glucose metabolism in the frontal & temporal lobes, consistent with FTD. (Courtesy N. Foster, MD & the University of Michigan PET Center.)
Axial T2WI MR in a 57-year-old woman with probable FTD shows temporal lobe atrophy with knife-like gyri
. The parietal & occipital lobes are relatively well preserved.
Axial T2WI MR in a 57-year-old woman with probable FTD shows temporal lobe atrophy with knife-like gyri
. The parietal & occipital lobes are relatively well preserved.
FDG PET in a patient with FTD shows marked hypometabolism in the frontal
& temporal
lobes. There is relative preservation of glucose metabolism in the occipital & parietal lobes
.
FDG PET in a patient with FTD shows marked hypometabolism in the frontal
& temporal
lobes. There is relative preservation of glucose metabolism in the occipital & parietal lobes
.
Sagittal SSP FDG PET scan in a 72-year-old man with FTD shows a normal elderly control map (2nd row), the patient's glucose metabolism (3rd row), & Z-score statistical map (bottom row). The frontal lobes
are strikingly hypometabolic. The temporal lobes
are somewhat less severely affected.
Sagittal SSP FDG PET scan in a 72-year-old man with FTD shows a normal elderly control map (2nd row), the patient's glucose metabolism (3rd row), & Z-score statistical map (bottom row). The frontal lobes
are strikingly hypometabolic. The temporal lobes
are somewhat less severely affected.
Coronal T1WI MR in the same patient shows focal atrophy of the olfactory gyri
. This finding was initially overlooked & the patient was given the imaging diagnosis of Alzheimer disease. Review & subsequent clinical evaluation confirmed FTD.
Coronal T1WI MR in the same patient shows focal atrophy of the olfactory gyri
. This finding was initially overlooked & the patient was given the imaging diagnosis of Alzheimer disease. Review & subsequent clinical evaluation confirmed FTD.
Axial FDG PET in a patient with FTD shows decreased glucose metabolism in frontal
& temporal
lobes. The parietal & occipital lobes
are spared.
Axial FDG PET in a patient with FTD shows decreased glucose metabolism in frontal
& temporal
lobes. The parietal & occipital lobes
are spared.
Sagittal FDG PET in the same patient with FTD depicts glucose hypometabolism in the frontal lobes
. The occipital lobes
are normal.
Sagittal FDG PET in the same patient with FTD depicts glucose hypometabolism in the frontal lobes
. The occipital lobes
are normal.
Coronal FDG PET in a patient with FTD exhibits glucose hypometabolism in frontal
and temporal lobes
.
Coronal FDG PET in a patient with FTD exhibits glucose hypometabolism in frontal
and temporal lobes
.
Axial T2WI MR in a patient with semantic dementia subtype of FTLD shows marked atrophy of anterolateral temporal lobes
. Note the relative preservation of the hippocampi
.
Axial T2WI MR in a patient with semantic dementia subtype of FTLD shows marked atrophy of anterolateral temporal lobes
. Note the relative preservation of the hippocampi
.
Axial NECT in a 78-year-old patient diagnosed with late-stage FTD through the upper lateral ventricles shows striking frontal lobar atrophy with classic knife-like gyri
characteristic of FTD. In contrast, the parietal & occipital lobes appear relatively spared.
Axial NECT in a 78-year-old patient diagnosed with late-stage FTD through the upper lateral ventricles shows striking frontal lobar atrophy with classic knife-like gyri
characteristic of FTD. In contrast, the parietal & occipital lobes appear relatively spared.
Axial FLAIR MR in a patient with early findings of FTD shows relatively mild frontal lobe volume loss
compared to the normal appearance of the parietal lobes.
Axial FLAIR MR in a patient with early findings of FTD shows relatively mild frontal lobe volume loss
compared to the normal appearance of the parietal lobes.
Axial FLAIR MR shows atrophy of both the frontal & temporal lobes. Note compensatory enlargement of the temporal horns
due to temporal lobe volume loss.
Sagittal T1WI MR shows predominantly frontal & temporal lobe atrophy. Some gyri demonstrate a classic knife-like appearance (
) reflecting severe atrophy of a gyrus.